WASHINGTON, D.C. — Significant differences in the level of concern over the potential cost of COVID-19 care exist between White Americans and non-White Americans. Over half (58%) of non-White adults versus 32% of White adults report that they are either “extremely concerned” or “concerned” about being able to pay for the cost of care if…

Read More

The pharmaceutical giant GlaxoSmithKline is starting human trials of the first medicine, a cancer drug, that has emerged from its two-year-old collaboration with consumer genetics firm 23andMe. The novel partnership focuses on using 23andMe’s massive genetic database, composed of the test results and self-reported health data from 12 million consumers who have taken its tests…

Read More

Has a second wave of COVID-19 already begun? Or are we still in the middle of the first wave exacerbated by opening up the economy too soon? Or is the uptick in hospitalizations the result of patients resuming the much-needed care they were forced put on pause as a result of the pandemic? Or is…

Read More

There are no “silver linings” in the dark cloud of Covid-19. Yet if history repeats itself, substantial biomedical innovation will emerge from this pandemic, as necessity fosters innovation. During World War II, the invention of deep-tank fermentation propelled the production of pharmaceutical-grade penicillin from 80 million units per month in 1942 to 650 billion units per month in 1945.…

Read More

President Donald Trump’s executive orders aimed at lowering U.S. prescription drug costs will cause “enormous destruction” as the pharmaceutical industry races to develop vaccines and treatments for the coronavirus, Pfizer CEO Albert Bourla told investors Tuesday. Trump on Friday signed four executive orders designed to bring U.S. drug prices at least on par with their costs overseas. “Overall, I’m disappointed with this…

Read More

Pfizer and German biotech partner BioNTech have on the same day as rival Moderna kick-started a late-stage effort for their “best” attempt at an mRNA pandemic vaccine. Moderna announced early Monday that, alongside a near half-billion extra in Biomedical Advanced Research and Development Authority dollars, it has started a boosted 30,000-patient phase 3 for its…

Read More

A new blood test for Alzheimer’s disease has shown it can be just as accurate or better than the current standards for diagnosis, performing nearly on par with potentially expensive PET brain scans and invasive spinal taps for cerebrospinal fluid. Presented at the Alzheimer’s Association International Conference, multiple researchers debuted studies demonstrating how certain proteins…

Read More

Governments may be able to prevent future pandemics by investing as little as $22 billion a year in programs to curb wildlife trafficking and stem the destruction of tropical forests, a new analysis shows. Compared to the $2.6 trillion already lost to COVID-19, and the more than 600,000 deaths the virus has caused so far,…

Read More

Dive Brief: FDA has authorized LabCorp’s COVID-19 test for use in the screening of people who have no reason to suspect they are infected with the coronavirus, the agency disclosed Friday. It marks the first time regulators have cleared a test for the screening of asymptomatic populations. FDA said the EUA may enable screening programs to support…

Read More